Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...

In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Cigna (CI – Research Report), with a price ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Cigna stated clearly in its release today that it is "not pursuing a combination with Humana." Investors had been wondering ...

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Humana shares are tumbling in premarket trading Monday after The Cigna Group said it is not pursuing a merger with its smaller health insurance rival.

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

Cigna said it isn't seeking to buy Humana, bolstering its stock and weighing on the share price of the Medicare-focused company. Cigna spoke out because of ongoing speculation it would strike a deal ...

(Reuters) -Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana. Shares of Cigna rose 3.2% in premarket trading, while Humana fell nearly 3%. Cigna said it would ...

The courtship between insurance giants Cigna and Humana is just not meant to be, Cigna officials said Monday. Why it matters: ...